Sotac Pharmaceuticals Limited (NSE:SOTAC)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Pharmaceuticals	1.02B	1.00B	1.04B	774.83M	731.52M
Pharmaceuticals Growth	1.33%	-3.57%	34.18%	5.92%	49.77%
Total	1.02B	1.00B	1.04B	774.83M	731.52M
Total Growth	1.33%	-3.57%	34.18%	5.92%	49.77%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	1.02B	1.00B	1.04B	769.09M	730.29M
India Growth	1.33%	-3.57%	35.18%	5.31%	49.52%
Export	-	-	-	5.75M	1.23M
Export Growth	-	-	-	368.76%	-
Total	1.02B	1.00B	1.04B	774.83M	731.52M
Total Growth	1.33%	-3.57%	34.18%	5.92%	49.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 16, 2026

Data Sources Report a data error